General Dermatology
Eczema
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management

TNF Inhibitors: Potential for Use in Dermatology Practice

August 1, 2003

Alice B. Gottlieb, MD, PhD

Article

Psoriasis is a chronic inflammatory disease characterized by well-demarcated red, raised, scaly lesions on any part of the body. The disease often severely impacts patients' mental and physical functioning and quality of life. Signs and symptoms may vary from mild to generalized cutaneous involvement, with or without associated joint disease.

Related Videos

Video 2 - "Atopic Dermatitis and Contact Dermatitis: Navigating Intersecting Pathways and Optimal Management Strategies"

Video 1 - "Decoding Atypical Atopic Dermatitis: Unraveling Complex Cases and Advanced Diagnostic Strategies"

Elizabeth Kiracofe, MD, an expert on atopic dermatitis

Related Content

Social Media’s Influence on Consumers, TrenibotulinumtoxinE, and More From the SEASON Aesthetic Conference

Social Media’s Influence on Consumers, TrenibotulinumtoxinE, and More From the SEASON Aesthetic Conference

The Cutaneous Connection: A Reminder of Patient Impact

The Cutaneous Connection: A Reminder of Patient Impact

Topical Antibiotic Treatment Significantly Reduced Depigmentation in Mouse Model

Topical Antibiotic Treatment Significantly Reduced Depigmentation in Mouse Model

The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

Insights Into Clear Health’s Low-Dose Microdose Accutane Protocol For Mild Acne

Insights Into Clear Health’s Low-Dose Microdose Accutane Protocol For Mild Acne

2 Years of Treatment With Dupilumab Led to Improvements In Symptoms of AD and Comorbid Anxiety, Depression

2 Years of Treatment With Dupilumab Led to Improvements In Symptoms of AD and Comorbid Anxiety, Depression

Related Content

Social Media’s Influence on Consumers, TrenibotulinumtoxinE, and More From the SEASON Aesthetic Conference

Social Media’s Influence on Consumers, TrenibotulinumtoxinE, and More From the SEASON Aesthetic Conference

The Cutaneous Connection: A Reminder of Patient Impact

The Cutaneous Connection: A Reminder of Patient Impact

Topical Antibiotic Treatment Significantly Reduced Depigmentation in Mouse Model

Topical Antibiotic Treatment Significantly Reduced Depigmentation in Mouse Model

The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

Insights Into Clear Health’s Low-Dose Microdose Accutane Protocol For Mild Acne

Insights Into Clear Health’s Low-Dose Microdose Accutane Protocol For Mild Acne

2 Years of Treatment With Dupilumab Led to Improvements In Symptoms of AD and Comorbid Anxiety, Depression

2 Years of Treatment With Dupilumab Led to Improvements In Symptoms of AD and Comorbid Anxiety, Depression

Do Not Sell My Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.